Potassium and Isoniazid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Isoniazid (isoniazid). Common drug interactions include malaise among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Isoniazid. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

What is Isoniazid?

Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

42 people who take Potassium and Isoniazid together, and have interactions are studied.

Potassium and Isoniazid drug interactions.

What are the common drug interactions of Potassium and Isoniazid, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Migraine (headache)
  3. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  4. Muscle spasms (muscle contraction)
  5. Muscular weakness (muscle weakness)
  6. Myalgia (muscle pain)
  7. Myopathy (a muscular disease in which the muscle fibres do not function)
  8. Nasal polyps (masses that develop in the lining of the nose)
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Nephrolithiasis (calculi in the kidneys)

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Fatigue (feeling of tiredness)
  3. Fungal infection
  4. Hepatic enzyme increased
  5. Hepatitis (inflammation of the liver)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Initial insomnia (feeling of inadequate or poor-quality sleep)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Maternal exposure during pregnancy (use of substance during pregnancy)
  10. Muscular weakness (muscle weakness)

What are the common drug interactions of Potassium and Isoniazid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cellulitis (infection under the skin)
  2. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Fungal infection
  5. Renal failure (kidney dysfunction)
  6. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

40-49:

  1. Hepatitis (inflammation of the liver)
  2. Lip swelling
  3. Swelling face

50-59:

  1. Upper respiratory tract infection
  2. Asthma
  3. Balance disorder
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Confusional state
  6. Decreased appetite
  7. Depression
  8. Fatigue (feeling of tiredness)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Osteoporosis (bones weak and more likely to break)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Drug ineffective
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Muscular weakness (muscle weakness)
  5. Myalgia (muscle pain)
  6. Nausea (feeling of having an urge to vomit)
  7. Pain
  8. Pain in extremity
  9. Peripheral swelling
  10. Pyrexia (fever)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 19.05%
  2. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 8 people, 19.05%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 19.05%
  4. Pain: 6 people, 14.29%
  5. High Blood Pressure: 5 people, 11.90%
  6. Multiple Myeloma (cancer of the plasma cells): 4 people, 9.52%
  7. Latent Tuberculosis (hidden tuberculosis): 4 people, 9.52%
  8. Nausea (feeling of having an urge to vomit): 3 people, 7.14%
  9. Interstitial Lung Disease: 3 people, 7.14%
  10. High Blood Cholesterol: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Isoniazid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isoniazid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on potassium and isoniazid (the active ingredients of Potassium and Isoniazid, respectively), and Potassium and Isoniazid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: